We are privileged to have wonderful supporters across our educational programs. Learn more about our sponsors by reading their descriptions and visiting their website below.
Abbott is a global leader in cardiovascular care, diabetes management, diagnostic testing, nutrition, pain and movement disorders, and more. In addition, through our partnerships we raise awareness for chronic disease prevention and other issues that impact global health.
We are a global, science-led, patient-focused pharmaceutical business. We are committed to excellence in the research, development and commercialisation of prescription medicines. We aim to transform the lives of patients with improved outcomes and a better quality of life.
At Bayer, our mission is straightforward: Health for all, Hunger for none. As a global leader in health and nutrition, we are committed to tackling the pressing challenges of our time, including a growing and aging population and the strain on our planet’s ecosystems. We have reimagined our entire operating model to ensure that we stay focused on our mission while driving sustainable growth and value for our customers, employees, and stakeholders.
We are Blood Cancer United, and we believe everyone with blood cancer deserves a longer, better life.That’s why we are on a mission to cure blood cancer and improve the quality of life of all patients and their families. How? We fund life-saving blood cancer research around the world, provide free information and support services for patients and their families, and are the voice for those seeking access to quality, affordable, coordinated care.
Cancer Health empowers people living with cancer to actively manage and advocate for their care and improve their overall health. Launched in 2017, the website provides accessible information about treatment and quality of life for people with cancer and their loved ones, as well as information about cancer prevention and health policy for a general readership.
CURE is the leading omni-channel resource for patients with cancer, survivors and their caregivers to become empowered advocates in their journeys. CURE® magazine and www.curetoday.com provide access to cancer news, updates, and educational events that serve as a guide to every stage of the cancer experience. Through our digital platforms, CURE® connects patients to one another, to expert insights from health care professionals and advocates, and highlights clinical trials opportunities.
Our mission is to help adolescent and young adult (AYA) patients, survivors, and caregivers know they are not alone in their experience with cancer. The Elephant in the room is cancer. Tea is the relief conversation provides. We are the only magazine written for and by the AYA cancer community telling their story in their own words. Elephants and Tea is the nonprofit media brand of the Steven G. Cancer Foundation
A Leading Global Research and Development-Based Pharmaceutical Company Headquartered in Japan. Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing, distribution and marketing, with a strong focus on prescription medicines.
Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
GSK is committed to maximizing patient survival through transformational medicines, with a current focus on breakthroughs in immuno-oncology and tumor-cell targeting therapies, and development in hematologic malignancies, gynecologic cancers and other solid tumors.
At Johnson & Johnson we believe good health is the foundation of vibrant lives, thriving communities and forward progress. We strive to not only innovate across MedTech and Innovative Medicine but to improve access and affordability to lifesaving and life-enhancing treatments and medical solutions around the world. We are able to do this because for more than 80 years, our commitment to helping people has been built into our mission statement and purpose
Kantor & Kantor, LLP was established in 2004 in Northridge, California, and has grown to six offices along the West Coast, with 21 attorneys and 26 professional staff members. We represent individuals in disputes with insurance companies over disability, life, long-term care, health, homeowners, and pension benefits. Our attorneys provide legal representation nationwide.
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
The mission of the Foundation is to remove barriers to quality healthcare across North America, with a special focus on vulnerable and under-resourced communities. Our expanding portfolio of nonprofit partners advances our work with efforts aligned with our three strategic giving pillars and corresponding areas of focus.
We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
Pfizer Oncology is committed to discovering, investigating, and developing transformative therapies that improve the outlook for cancer patients worldwide.
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and creating compelling growth. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives.